Soluble IL-2R  facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma

Soluble IL-2RA Levels in Multiple Sclerosis Subjects and the Effect of Soluble IL-2RA on Immune Responses

(2014) L. M. Maier et al.   JOURNAL OF IMMUNOLOGY

T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignancies

(2010) Camilla A. Lindqvist et al.   IMMUNOLOGY

Clostridium difficile-associated diarrhoea, a frequent complication in patients with acute myeloid leukaemia

(2009) Enrico Schalk et al.   ANNALS OF HEMATOLOGY

Malignant B Cells Skew the Balance of Regulatory T Cells and TH17 Cells in B-Cell Non-Hodgkin's Lymphoma

(2009) Zhi-Zhang Yang et al.   CANCER RESEARCH

Serum soluble interleukin-2 receptor level and immunophenotype are prognostic factors for patients with diffuse large B-cell lymphoma

(2009) Toshiaki Morito et al.   CANCER SCIENCE

Soluble interleukin-2 receptor retains prognostic value in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP (RCHOP) therapy

(2008) D. Ennishi et al.   ANNALS OF ONCOLOGY

Prognostic value of serum soluble interleukin-2 receptor level in patients with diffuse large B cell lymphoma, treated with CHOP- or RCHOP-based therapy

(2008) Yasuhiro Oki et al.   LEUKEMIA & LYMPHOMA

Natural and TGF-β–induced Foxp3+CD4+ CD25+ regulatory T cells are not mirror images of each other

(2008) David A. Horwitz et al.   TRENDS IN IMMUNOLOGY